OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
Koichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210780-e2210780
Open Access | Times Cited: 37
Koichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210780-e2210780
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
Birte Möhlendick, Ieva Čiučiulkaitė, Carina Elsner, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Birte Möhlendick, Ieva Čiučiulkaitė, Carina Elsner, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
Luca Perico, Marta Todeschini, Federica Casiraghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Luca Perico, Marta Todeschini, Federica Casiraghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort
Masae Itamochi, Shunsuke Yazawa, Noriko Inasaki, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2234-2242
Open Access | Times Cited: 14
Masae Itamochi, Shunsuke Yazawa, Noriko Inasaki, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2234-2242
Open Access | Times Cited: 14
Increased Secondary Attack Rates among the Household Contacts of Patients with the Omicron Variant of the Coronavirus Disease 2019 in Japan
Tsuyoshi Ogata, Hideo Tanaka, Emiko Tanaka, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 8068-8068
Open Access | Times Cited: 17
Tsuyoshi Ogata, Hideo Tanaka, Emiko Tanaka, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 8068-8068
Open Access | Times Cited: 17
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
Toon Braeye, Joris Adriaan Frank van Loenhout, Ruben Brondeel, et al.
Eurosurveillance (2023) Vol. 28, Iss. 26
Open Access | Times Cited: 11
Toon Braeye, Joris Adriaan Frank van Loenhout, Ruben Brondeel, et al.
Eurosurveillance (2023) Vol. 28, Iss. 26
Open Access | Times Cited: 11
IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
Norma C. Serrano, Claudia Carolina Colmenares Mejía, Doris Cristina Quintero-Lesmes, et al.
Revista de Investigación e Innovación en Ciencias de la Salud (2025) Vol. 7, Iss. 2
Open Access
Norma C. Serrano, Claudia Carolina Colmenares Mejía, Doris Cristina Quintero-Lesmes, et al.
Revista de Investigación e Innovación en Ciencias de la Salud (2025) Vol. 7, Iss. 2
Open Access
Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants
Isabela Pazotti Daher, Bianca da Silva Almeida, Guilherme Antonio de Souza Silva, et al.
Clinical Immunology (2025), pp. 110492-110492
Closed Access
Isabela Pazotti Daher, Bianca da Silva Almeida, Guilherme Antonio de Souza Silva, et al.
Clinical Immunology (2025), pp. 110492-110492
Closed Access
Viral escape-inspired framework for structure-guided dual bait protein biosensor design
Yee Chuen Teoh, Mohammed Sakib Noor, Sina Aghakhani, et al.
PLoS Computational Biology (2025) Vol. 21, Iss. 4, pp. e1012964-e1012964
Open Access
Yee Chuen Teoh, Mohammed Sakib Noor, Sina Aghakhani, et al.
PLoS Computational Biology (2025) Vol. 21, Iss. 4, pp. e1012964-e1012964
Open Access
Neutralizing antibody responses to SARS-CoV-2 variants after COVID-19 vaccination and boosters
Kabita Adhikari, Subhash C. Verma
Vaccine X (2025), pp. 100664-100664
Open Access
Kabita Adhikari, Subhash C. Verma
Vaccine X (2025), pp. 100664-100664
Open Access
Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses
Qianqian Li, Li Zhang, Ziteng Liang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Qianqian Li, Li Zhang, Ziteng Liang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 6, pp. 1643-1658
Open Access | Times Cited: 16
Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 6, pp. 1643-1658
Open Access | Times Cited: 16
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 15
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 15
Real-World Effectiveness of a Booster Dose of the COVID-19 Vaccines among Japanese University Students
Shunsuke Miyauchi, Toru Hiyama, Yukiko Nakano, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1283-1283
Open Access | Times Cited: 13
Shunsuke Miyauchi, Toru Hiyama, Yukiko Nakano, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1283-1283
Open Access | Times Cited: 13
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India
Bhagwat Gunale, Dhananjay Kapse, Sonali Kar, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 9, pp. 911-911
Closed Access | Times Cited: 7
Bhagwat Gunale, Dhananjay Kapse, Sonali Kar, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 9, pp. 911-911
Closed Access | Times Cited: 7
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants
Hanako Ishimaru, Mitsuhiro Nishimura, Lidya Handayani Tjan, et al.
Journal of Virology (2023) Vol. 97, Iss. 6
Open Access | Times Cited: 6
Hanako Ishimaru, Mitsuhiro Nishimura, Lidya Handayani Tjan, et al.
Journal of Virology (2023) Vol. 97, Iss. 6
Open Access | Times Cited: 6
Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
Masahiro Shirata, Isao Ito, Masao Tanaka, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4707-4720
Closed Access | Times Cited: 5
Masahiro Shirata, Isao Ito, Masao Tanaka, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4707-4720
Closed Access | Times Cited: 5
Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge
E. Gary, Nicholas J. Tursi, Bryce M. Warner, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
E. Gary, Nicholas J. Tursi, Bryce M. Warner, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Humoral and cellular immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield)
Himanshu Dandu, Amit Goel, Manish Kumar, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Himanshu Dandu, Amit Goel, Manish Kumar, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico
Erika Garay, Sean P. J. Whelan, Rebecca M. DuBois, et al.
Epidemiology and Infection (2024) Vol. 152
Open Access | Times Cited: 1
Erika Garay, Sean P. J. Whelan, Rebecca M. DuBois, et al.
Epidemiology and Infection (2024) Vol. 152
Open Access | Times Cited: 1
Real-World Data on Neutralizing Antibody and Safety of COVID-19 Vaccine against SAR-CoV2 Wild Type and Omicron Variant in Solid Cancer Patients
B. Chewaskulyong, Pattarapong Satjaritanun, Apichat Tantraworasin, et al.
(2024)
Open Access | Times Cited: 1
B. Chewaskulyong, Pattarapong Satjaritanun, Apichat Tantraworasin, et al.
(2024)
Open Access | Times Cited: 1
Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review
Sabina Rodriguez Velásquez, Loza Biru, Sandrine Marie Hakiza, et al.
Schweizerische medizinische Wochenschrift (2024) Vol. 154, Iss. 5, pp. 3732-3732
Open Access | Times Cited: 1
Sabina Rodriguez Velásquez, Loza Biru, Sandrine Marie Hakiza, et al.
Schweizerische medizinische Wochenschrift (2024) Vol. 154, Iss. 5, pp. 3732-3732
Open Access | Times Cited: 1
Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination
Yukiya Kurahashi, Koichi Furukawa, Silvia Sutandhio, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1391-1395
Open Access | Times Cited: 6
Yukiya Kurahashi, Koichi Furukawa, Silvia Sutandhio, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1391-1395
Open Access | Times Cited: 6
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility
Claudia Maria Trombetta, Serena Marchi, Margherita Leonardi, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 6
Claudia Maria Trombetta, Serena Marchi, Margherita Leonardi, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 6
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
Silvia Sutandhio, Koichi Furukawa, Yukiya Kurahashi, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 7, pp. 1064-1072
Open Access | Times Cited: 3
Silvia Sutandhio, Koichi Furukawa, Yukiya Kurahashi, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 7, pp. 1064-1072
Open Access | Times Cited: 3
Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination
Lidya Handayani Tjan, Koichi Furukawa, Yukiya Kurahashi, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1481-1483
Open Access | Times Cited: 5
Lidya Handayani Tjan, Koichi Furukawa, Yukiya Kurahashi, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1481-1483
Open Access | Times Cited: 5
